At Shockwave, innovation is in our DNA. We never settle for the status quo and are constantly exploring ways to address unmet clinical needs with low-risk treatment options for underserved patients suffering from cardiovascular disease. That’s why our investment in research and development continues to grow year after year, and now, as part of Johnson & Johnson MedTech, we’re more excited than ever about what the future holds. From Intravascular Lithotripsy (IVL) to Coronary Sinus Reduction and beyond, our technologies – and our people – are making waves.
At Shockwave Medical, we’re committed to our values and make sure they drive everything we do.
Commitment beyond compare, with leaders dedicated to their teams. Meet the Shockwave leadership team.
Ready to help us disrupt the status quo and improve the lives of patients across the globe?